Pilot study on the effect of estrogen replacement therapy on brain dopamine transporter availability in healthy, postmenopausal women

American Journal of Geriatric Psychiatry

Volumn 12, Issue 6, 2004, Pages 621-630

  Gardiner, Sara Anne ^e,f   Morrison, Mary F ^a,b   Mozley, P David ^c   Mozley, Lyn Harper ^d   Brensinger, Colleen ^a   Bilker, Warren ^a   Newberg, Andrew ^a   Battistini, Michelle ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

^c ELI LILLY AND COMPANY   (United States)

^d INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e ePharmaLearning Inc   (United States)

^f ePharmaLearning Inc ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONJUGATED ESTROGEN; DOPAMINE TRANSPORTER; ESTROGEN; MEDROXYPROGESTERONE ACETATE; PROGESTERONE; RADIOLIGAND; [2 [[2 [[[3 (4 CHLOROPHENYL) 8 METHYL 8 AZABICYCLO[3.2.1]OCT 2 YL]METHYL](2 MERCAPTOETHYL)AMINO]ETHYL]AMINO]ETHANETHIOLATO]OXOTECHNETIUM TC 99M; CARRIER PROTEIN; DIAGNOSTIC AGENT; MEMBRANE PROTEIN; NERVE PROTEIN; SLC6A3 PROTEIN, HUMAN; TECHNETIUM COMPLEX; TECHNETIUM TC 99M TRODAT 1; TECHNETIUM TC 99M TRODAT-1; TROPANE DERIVATIVE;

ADULT; AGED; ARTICLE; CAUDATE NUCLEUS; CLINICAL ARTICLE; COLLIMATOR; DOPAMINERGIC SYSTEM; DRUG UPTAKE; ESTRADIOL BLOOD LEVEL; ESTROGEN DEFICIENCY; ESTROGEN THERAPY; FEMALE; HORMONE SUBSTITUTION; HUMAN; IMAGE ANALYSIS; LIGAND BINDING; NEUROIMAGING; PILOT STUDY; POSTMENOPAUSE; PROGESTERONE BLOOD LEVEL; PUTAMEN; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TREATMENT OUTCOME; BRAIN; DRUG EFFECT; HEMISPHERIC DOMINANCE; METABOLISM; MIDDLE AGED; PHYSIOLOGY; REFERENCE VALUE; SCINTISCANNING;

AGED; AGED, 80 AND OVER; BRAIN; DOMINANCE, CEREBRAL; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; ESTROGEN REPLACEMENT THERAPY; ESTROGENS, CONJUGATED (USP); FEMALE; HUMANS; MEDROXYPROGESTERONE 17-ACETATE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MIDDLE AGED; NERVE TISSUE PROTEINS; ORGANOTECHNETIUM COMPOUNDS; POSTMENOPAUSE; PUTAMEN; REFERENCE VALUES; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TROPANES;

EID: 16644370196     PISSN: 10647481     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019442-200411000-00008     Document Type: Article

References (32)

1. Suhara T, Fukuda H, Inoue O, et al: Age-related changes in human D1 dopamine receptors measured by positron-emission tomography. Psychopharmacol 1991; 103:41-45
2. 2 receptor binding with iodine-123-iodobenzofuran SPECT. J Nucl Med 1998; 39:1511-1518
3. Volkow ND, Fowler JS, Wang GJ, et al: Decreased dopamine transporters with age in healthy human subjects. Ann Neurol 1994; 36:237-239
4. 123 IPT SPECT imaging of CNS dopamine transporters: nonlinear effects of normal aging on striatal uptake values. J Nucl Med 1996; 37:1965-1970
5. Bosse R, Rivest R, Di Paolo T: Ovariectomy and estradiol treatment affect the dopamine transporter and its gene expression in the rat brain. Brain Res Mol Brain Res 1997; 46:343-346
6. A receptor imbalance after ovariectomy in rats: model of menopause. J Psychiatry Neurosci 1995; 20:364-371
7. 1 dopamine receptors. Life Sci 1989; 45:1813-1820
8. Di Paolo T, Bedard PJ, Dupont A, et al: Effects of estradiol on intact and denervated striatal dopamine receptors and on dopamine levels: a biochemical and behavioral study. Can J Physiol Pharmacol 1982; 60:350-357
9. Pasqualini C, Olivier V, Guibert B, et al: Acute stimulatory effect of estradiol on striatal dopamine synthesis. J Neurochem 1995; 65:1651-1657
10. Smith RL, Van Hartesveldt C: Effects of ovariectomy and estrogen replacement on intrastriatal dopamine-elicited postural deviation. Pharmacol Biochem Behav 1985; 22:689-693
11. Hafner H, Riecher-Rossler A, Maurer K, et al: First onset and early symptomatology of schizophrenia: a chapter of epidemiological and neurobiological research into age and sex differences. Eur Arch Psychiatry Clin Neurosci 1992; 242:109-118
12. Riecher-Rossler A, Hafner H, Stumbaum M, et al: Can estradiol modulate schizophrenic symptomatology? Schizophr Bull 1994; 20:203-214
13. Lindamer LA, Buse DC, Lohr JB, et al: Hormone replacement therapy in postmenopausal women with schizophrenia: positive effect on negative symptoms? Biol Psychiatry 2001; 49:47-51
14. Bower JH, Maraganore DM, McDonnell SK, et al: Incidence and distribution of parkinsonism in Olmsted County, Minnesota, 1976-1990. Neurology 1999; 52:1214-1220
15. Benedetti MD, Maraganore DM, Bower JH, et al: Hysterectomy, menopause, and estrogen use preceding Parkinson's disease: an exploratory case-control study. Mov Disord 2001; 16:830-837
16. 17beta-estradiol in postmenopausal PD patients: a crossover study. Neurology 1999; 53:91-95
17. Tsang KL, Ho SL, Lo SK: Estrogen improves motor disability in parkinsonian postmenopausal women with motor fluctuations. Neurology 2000; 54:2292-2298
18. Strijks E, Kremer JA, Horstink MW: Effects of female sex steroids on Parkinson's disease in postmenopausal women. Clin Neuropharmacol 1999; 22:93-97
19. Mozley PD, Stubbs JB, Plossl K, et al: Biodistribution and dosimetry of TRODAT-1: a technetium-99m tropane for imaging dopamine transporters. J Nucl Med 1998; 39:2069-2076
20. Kung MP, Stevenson DA, Plossl K, et al: [99mTc]TRODAT-1: a novel technetium-99m complex as a dopamine transporter imaging agent. Eur J Nucl Med 1997; 24:372-380
21. Jaber M, Jones S, Giros B, et al: The dopamine transporter: a crucial component regulating dopamine transmission. Mov Disord 1997; 12:629-633
22. Folstein MF, Folstein SE, McHugh PR: "Mini-Mental State:" a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12:189-198
23. Radloff L: The CES-D scale: a self-report depression scale for research in the general population. Applied Psychological Measurement 1977; 1:385-401
24. Mozley LH, Gur RC, Mozley PD, et al: Striatal dopamine transporters and cognitive functioning in healthy men and women. Am J Psychiatry 2001; 158:1492-1499
25. Linn BS, Linn MW, Gurel L: Cumulative Illness Rating Scale. J Am Geriatr Soc 1968; 16:622-626
26. Hwang WJ, Yao WJ, Wey SP, et al: Reproducibility of 99mTc-TRODAT-1 SPECT measurement of dopamine transporters in Parkinson's disease. J Nucl Med 2004; 45:207-213
27. Mozley PD, Acton PD, Barraclough ED, et al: Effects of age on dopamine transporters in healthy humans. J Nucl Med 1999; 40:1812-1817
28. Mozley PD, Schneider JS, Acton PD, et al: Binding of [99mTc]TRODAT-1 to dopamine transporters in patients with Parkinson's disease and in healthy volunteers. J Nucl Med 2000; 41:584-589
29. Kao PF, Tzen KY, Yen TC, et al: The optimal imaging time for [99Tcm]TRODAT-1/SPET in normal subjects and patients with Parkinson's disease. Nucl Med Commun 2001; 22:151-154
30. Harris HA, Bapat AR, Gonder DS, et al: The ligand-binding profiles of estrogen receptors alpha and beta are species-dependent. Steroids 2002; 67:379-384
31. Pau CY, Pau KY, Spies HG: Putative estrogen receptor beta- and alpha- mRNA expression in male and female rhesus macaques. Mol Cell Endocrinol 1998; 146:59-68
32. Kish SJ, Shannak K, Hornykiewicz O: Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease: pathophysiologic and clinical implications. N Engl J Med 1988; 318:876-880